EUDA Health Holdings Limited announced its financial results for the full year 2024 on May 2, 2025. The company reported revenue of US$4.01 million, an increase of 8.2% from fiscal year 2023.
Despite the revenue growth, the company's loss per share increased to US$0.54 for the full year 2024, compared to a loss of US$0.37 per share in fiscal year 2023. Net income from continuing operations was -$17.60 million in 2024, compared to -$8.44 million in 2023.
Operating income remained negative at -$2.58 million in 2024, with a gross profit of $762,155. The company's TTM Gross Profit Margin was 19.00%, Operating Profit Margin (TTM) was -47.08%, and Net Profit Margin (TTM) stood at -881.94%, highlighting severe operational inefficiencies and substantial losses.
These results indicate that while EUDA achieved some revenue growth, its profitability challenges intensified during 2024. The company continues to face significant financial distress as it pursues its strategic transformation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.